CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 230 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $56 | +21.7% | 2,074 | -0.7% | 0.00% | – |
| Q2 2023 | $46 | 0.0% | 2,088 | -2.2% | 0.00% | – |
| Q1 2023 | $46 | +411.1% | 2,134 | +392.8% | 0.00% | – |
| Q4 2022 | $9 | -99.9% | 433 | -23.0% | 0.00% | – |
| Q3 2022 | $14,000 | +366.7% | 562 | +295.8% | 0.00% | – |
| Q2 2022 | $3,000 | -25.0% | 142 | -10.7% | 0.00% | – |
| Q1 2022 | $4,000 | 0.0% | 159 | -29.3% | 0.00% | – |
| Q4 2021 | $4,000 | +300.0% | 225 | +508.1% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 37 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 37 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | 0.0% | 37 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 37 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 37 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | 0.0% | 37 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | 0.0% | 37 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 37 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | 0.0% | 37 | 0.0% | 0.00% | – |
| Q1 2019 | $1,000 | – | 37 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 5,188,417 | $85,349,000 | 7.80% |
| TANAKA CAPITAL MANAGEMENT INC | 144,602 | $2,379,000 | 5.69% |
| INGALLS & SNYDER LLC | 6,817,540 | $112,149,000 | 5.47% |
| NEXTHERA CAPITAL LP | 1,045,196 | $17,193,000 | 2.83% |
| Timpani Capital Management LLC | 245,279 | $4,035,000 | 1.41% |
| S&T BANK/PA | 426,257 | $7,012,000 | 1.25% |
| SHAKER INVESTMENTS LLC/OH | 107,670 | $1,771,000 | 1.10% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 434,624 | $7,150,000 | 0.94% |
| AMI ASSET MANAGEMENT CORP | 709,300 | $11,668,000 | 0.83% |
| Birchview Capital, LP | 75,500 | $1,242,000 | 0.82% |